EP Patent
EP2328553B1 — Corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
Assigned to University of California · Expires 2020-06-10 · 6y expired
What this patent protects
Patent listed against Pulmicort Respules.
Drugs covered by this patent
- Pulmicort Respules (BUDESONIDE) · AstraZeneca K.K.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.